Quest Diagnostics Incorporated Stock Performance

DGX Stock  USD 202.44  1.95  0.95%   
Quest Diagnostics has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of 0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, Quest Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest Diagnostics is expected to be smaller as well. Quest Diagnostics right now holds a risk of 1.68%. Please check Quest Diagnostics standard deviation, expected short fall, relative strength index, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Quest Diagnostics will be following its historical price patterns.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, Quest Diagnostics may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more

Actual Historical Performance (%)

One Day Return
(0.95)
Five Day Return
(2.43)
Year To Date Return
16.49
Ten Year Return
205.29
All Time Return
5.7 K
Forward Dividend Yield
0.0168
Payout Ratio
0.3249
Last Split Factor
2:1
Forward Dividend Rate
3.44
Dividend Date
2026-04-20
1
Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
01/06/2026
2
Nordea Investment Management AB Trims Holdings in Quest Diagnostics Incorporated DGX - MarketBeat
01/16/2026
 
Quest Diagnostics dividend paid on 28th of January 2026
01/28/2026
3
A Look At Quest Diagnostics Valuation After Barclays Upgrade And Earnings Growth Optimism
02/02/2026
4
Why Is Quest Stock Soaring Today
02/10/2026
5
Mystic Aquarium makes splashy Stonington buy, but plans remain a mystery
02/11/2026
6
Quest Diagnostics Testing Volume Growth Tracks SP 500
02/12/2026
7
Quest Diagnostics Incorporated DGX Shares Sold by Cookson Peirce Co. Inc.
02/13/2026
8
Labcorp forecasts upbeat annual profit on strong demand for diagnostic products
02/17/2026
9
Should semen analysis become the Pap smear for men Some mens health experts say yes
02/19/2026
Begin Period Cash Flow549 M
Total Cashflows From Investing Activities-631 M

Quest Diagnostics Relative Risk vs. Return Landscape

If you would invest  18,971  in Quest Diagnostics Incorporated on November 22, 2025 and sell it today you would earn a total of  1,273  from holding Quest Diagnostics Incorporated or generate 6.71% return on investment over 90 days. Quest Diagnostics Incorporated is generating 0.1238% of daily returns assuming volatility of 1.6824% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Quest, and above 98% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Quest Diagnostics is expected to generate 2.24 times more return on investment than the market. However, the company is 2.24 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Quest Diagnostics Target Price Odds to finish over Current Price

The tendency of Quest Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 202.44 90 days 202.44 
roughly 2.55
Based on a normal probability distribution, the odds of Quest Diagnostics to move above the current price in 90 days from now is roughly 2.55 (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Quest Diagnostics has a beta of 0.15 suggesting as returns on the market go up, Quest Diagnostics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Quest Diagnostics Incorporated will be expected to be much smaller as well. Additionally Quest Diagnostics Incorporated has an alpha of 0.1169, implying that it can generate a 0.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Quest Diagnostics Price Density   
       Price  

Predictive Modules for Quest Diagnostics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quest Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
201.99203.66205.33
Details
Intrinsic
Valuation
LowRealHigh
178.86180.53222.62
Details
Naive
Forecast
LowNextHigh
210.49212.16213.83
Details
19 Analysts
Consensus
LowTargetHigh
197.81217.38241.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Quest Diagnostics. Your research has to be compared to or analyzed against Quest Diagnostics' peers to derive any actionable benefits. When done correctly, Quest Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Quest Diagnostics.

Quest Diagnostics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Quest Diagnostics is not an exception. The market had few large corrections towards the Quest Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Quest Diagnostics Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Quest Diagnostics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.12
β
Beta against Dow Jones0.15
σ
Overall volatility
9.07
Ir
Information ratio 0.04

Quest Diagnostics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quest Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quest Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Quest Diagnostics has a strong financial position based on the latest SEC filings
On 28th of January 2026 Quest Diagnostics paid $ 0.8 per share dividend to its current shareholders
Latest headline from statnews.com: Should semen analysis become the Pap smear for men Some mens health experts say yes

Quest Diagnostics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quest Stock often depends not only on the future outlook of the current and potential Quest Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding113 M
Cash And Short Term Investments420 M

Quest Diagnostics Fundamentals Growth

Quest Stock prices reflect investors' perceptions of the future prospects and financial health of Quest Diagnostics, and Quest Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quest Stock performance.

About Quest Diagnostics Performance

Evaluating Quest Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Quest Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Quest Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 9.18  10.25 
Return On Tangible Assets 0.18  0.14 
Return On Capital Employed 0.11  0.10 
Return On Assets 0.06  0.04 
Return On Equity 0.14  0.08 

Things to note about Quest Diagnostics performance evaluation

Checking the ongoing alerts about Quest Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Quest Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Quest Diagnostics has a strong financial position based on the latest SEC filings
On 28th of January 2026 Quest Diagnostics paid $ 0.8 per share dividend to its current shareholders
Latest headline from statnews.com: Should semen analysis become the Pap smear for men Some mens health experts say yes
Evaluating Quest Diagnostics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Quest Diagnostics' stock performance include:
  • Analyzing Quest Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quest Diagnostics' stock is overvalued or undervalued compared to its peers.
  • Examining Quest Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Quest Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quest Diagnostics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Quest Diagnostics' stock. These opinions can provide insight into Quest Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Quest Diagnostics' stock performance is not an exact science, and many factors can impact Quest Diagnostics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.